Going beyond genomics in precision oncology
Crossref DOI link: https://doi.org/10.1038/s41591-025-04153-0
Published Online: 2026-01-06
Published Print: 2026-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Paassen, Irene
Rubin, Mark A.
Text and Data Mining valid from 2026-01-06
Version of Record valid from 2026-01-06
Article History
First Online: 6 January 2026
Competing interests
: M.A.R. serves on the scientific advisory board of Owkin and is a stockholder in the company. He is also a co-founder of Verintas Therapeutics.